I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A Phase II Study to Evaluate the Safety and Efficacy of Pra..:
Pagano, Gennaro
;
Boess, Frank G
;
Taylor, Kirsten I
...
qt2tv8r5dg. , 2021
Link:
https://escholarship.org/uc/item/2tv8r5dg
RT Journal T1
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt2tv8r5dg&Exemplar=1&LAN=DE A1 Pagano, Gennaro A1 Boess, Frank G A1 Taylor, Kirsten I A1 Ricci, Benedicte A1 Mollenhauer, Brit A1 Poewe, Werner A1 Boulay, Anne A1 Anzures-Cabrera, Judith A1 Vogt, Annamarie A1 Marchesi, Maddalena A1 Post, Anke A1 Nikolcheva, Tania A1 Kinney, Gene G A1 Zago, Wagner M A1 Ness, Daniel K A1 Svoboda, Hanno A1 Britschgi, Markus A1 Ostrowitzki, Susanne A1 Simuni, Tanya A1 Marek, Kenneth A1 Koller, Martin A1 Sevigny, Jeff A1 Doody, Rachelle A1 Fontoura, Paulo A1 Umbricht, Daniel A1 Bonni, Azad A1 Investigators, PASADENA A1 Group, Prasinezumab Study A1 Altendorf, Claudia A1 Anandan, Chareyna A1 Andrews, Giulia A1 Ansquer, Solène A1 Arrouasse, Raphaele A1 Aslam, Sana A1 Azulay, Jean-Philippe A1 Baker, Jeanette A1 Martinez, Ernest Balaguer A1 Barbu, Shadi A1 Bardram, Kara A1 Bega, Danny A1 Marco, Helena Bejr-Kasem A1 Benatru, Isabelle A1 Benchetrit, Eve A1 Bernhard, Felix A1 Besharat, Amir A1 Bette, Sagari A1 Bichon, Amelie A1 Billnitzer, Andrew A1 Blondeau, Sophie A1 Boraud, Thomas A1 Borngräber, Freiderike A1 Boyd, James A1 Brockmann, Kathrin A1 Brodsky, Matthew A1 Brown, Ethan A1 Bruecke, Christof A1 Calvas, Fabienne A1 Canelo, Monica A1 Carbone, Federico A1 Carroll, Claire A1 Fernandez, Laura Casado A1 Cassé-Perrot, Catherine A1 Castrioto, Anna A1 Catala, Helene A1 Chan, Justine A1 Cheriet, Samia A1 Ciabarra, Anthony A1 Classen, Joseph A1 Coleman, Juliana A1 Coleman, Robert A1 Compta, Yaroslau A1 Corbillé, Anne-Gaëlle A1 Corvol, Jean-Christophe A1 Cosgaya, Mariana A1 Dahodwala, Nabila A1 Damier, Philippe A1 David, Elodie A1 Davis, Thomas A1 Dean, Marissa A1 Debilly, Berengere A1 DeGiorgio, Janell A1 Deik, Andres A1 Delaby, Laure A1 Delfini, Marie-Helene A1 Derkinderen, Pascal A1 Derost, Philipp A1 de Toledo, Maria A1 Deuel, Lisa A1 Diaz-Hernandez, Ann Marie A1 Dietiker, Cameron A1 Dimenshteyn, Karina A1 Dotor, Julio A1 Durif, Franck A1 Ebentheuer, Jens A1 Eggert, Karla Maria A1 Madueño, Sara Eichau A1 Eickhoff, Claudia A1 Ellenbogen, Aaron A1 Ellmerer, Philipp A1 Vazquez, Ines Esparragosa PB eScholarship, University of California YR 2021 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Neurodegenerative K1 Parkinson's Disease K1 Clinical Research K1 Neurosciences K1 Aging K1 Clinical Trials and Supportive Activities K1 Brain Disorders K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Neurological K1 PASADENA Investigators K1 Prasinezumab Study Group K1 MDS-UPDRS = Movement Disorder Society—Unified Parkinson's Disease Rating Scale K1 Phase II clinical trial K1 alpha-synuclein K1 disease modification treatments K1 disease progression K1 monoclonal antibodies K1 prasinezumab K1 Psychology K1 Biological psychology JF qt2tv8r5dg LK http://dx.doi.org/https://escholarship.org/uc/item/2tv8r5dg DO https://escholarship.org/uc/item/2tv8r5dg SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)